Cheap As Water? Insulin Users, Pricing Experts Question Trump’s Claim
During the first presidential debate, Donald Trump highlighted his efforts to lower the costs of prescription drugs like insulin. His statement is fact checked.
The independent source for health policy research, polling, and news.
18,221 - 18,240 of 112,693 Results
During the first presidential debate, Donald Trump highlighted his efforts to lower the costs of prescription drugs like insulin. His statement is fact checked.
"We conclude that the President of the United States was likely the largest driver of the COVID-19 misinformation 'infodemic,'" said Cornell University researchers after analyzing 38 million English-language online articles about the pandemic. Other reports of President Donald Trump twisting the facts are also in the news.
As the U.S. experienced historic job-loss rates between February and June, over 4 million Americans enrolled in Medicaid and the Children's Health Insurance Program, CMS reports.
House Democrats delayed a planned vote on their latest $2.2 trillion coronavirus relief bill, to allow more time for talks between the White House and House negotiators.
Democrats on the House Oversight Committee began releasing two investigation reports that cite internal company documents on the day the CEOs of Teva, Celgene and Bristol Myers Squibb testified before the panel. Amgen, Mallinckrodt and Novartis executives are scheduled to appear Thursday.
Today's early morning highlights from the major news organizations.
Opinion writers weigh in on these pandemic issues and others.
Read recent commentaries about drug-cost issues.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
Editorial writers focus on public health care topics and strategies of the first debate between President Donald Trump and Vice President Joe Biden.
News is on new restrictions in Canada, the World Bank's commitment to help poor countries, the low caseload in Sweden and more.
News is from Kentucky, Missouri, Oklahoma, Texas, Connecticut, and Florida.
A number of studies reveal it's twice as contagious as thought, that young people are driving the spread of the virus and obesity's role is made clearer.
"It’s really knowing about your own environment and what’s going on in your neighborhood in your area to really make decisions whether or not to trick-or-treat,” advised Jared Muenzer, pediatric emergency room doctor and physician-in-chief at Phoenix Children’s Hospital. News is on a novel way to feed the homeless, dangers of stability balls and updates on the NFL and NHL.
The impact is disproportionately high for Hispanic and Black households, a new poll finds.
And a very healthy college student died of COVID complications. Other news about the pandemic and schools is from Iowa, Mississippi and Maryland.
Lack of affordable coverage was the top reason given for being uninsured. Other marketplace and health industry news is from United HealthCare, St. Luke’s Health System, Children’s Mercy, Baylor St. Luke’s Medical Center, Molina Healthcare, Affinity Health Plan, Baptist Hospitals and more.
The health giant's network remained shut down as of Tuesday. Health workers say the outage has made communicating difficult and that they are using paper records and hand-labeling medications. The Wall Street Journal said some ambulances have been re-routed and elective surgeries canceled.
United Health buys DivvyDose for just over $300 million in order to compete against Amazon's PillPack. Other industry news makes headlines as well.
The drugmaker says that its two-antibody cocktail, dubbed REGN-COV, lowered viral loads and improved symptoms for non-hospitalized patients in a small clinical trial. The therapy is also being tested in hospitalized patients with more severe symptoms. Regeneron says it is in early discussions with the FDA about possibly applying for emergency use authorization.
© 2026 KFF